A trial of a subcutaneously administered glycoprotein IIb/IIIa inhibitor for ST-elevation myocardial infarction demonstrates improvement in key cardiovascular outcomes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/prehospital-subcutaneous-antiplatelet-improves-stemi-vessel-2025a1000wgv?src=rss
Author :
Publish date : 2025-11-21 10:38:00
Copyright for syndicated content belongs to the linked Source.
